Tumor-Agnostic AKT Inhibition: Is It Time to AKT? Dahmer Tiecher R, Schram AM. Clin Cancer Res 2025;31:4863-4865.

Read + Share

Amedeo Smart

Independent Medical Education

Dahmer Tiecher R, Schram AM. Tumor-Agnostic AKT Inhibition: Is It Time to AKT? Clin Cancer Res 2025;31:4863-4865.
PMID: 41026470